Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

▤ Summary

Vivos Therapeutics announced a collaboration with a Florida cardiology group to expand sleep apnea and insomnia diagnosis and treatment for cardiovascular patients. The company plans to form AIM Florida as a physician-aligned management services organization and expects to hold at least 80% of the membership interests. The model targets an initial Palm Beach County launch and could later expand to other Florida markets and cardiology practices nationwide. Vivos says the structure avoids the capital intensity of an acquisition while creating a scalable clinical-services platform. The release also notes that definitive agreements still need to be negotiated and regulatory compliance remains a key requirement.

▦ Linked Companies